Skip to content

Simplexa™ Group A Strep Direct MOL2850

by DiaSorin Molecular LLC

Simplexa™ Group A Strep Direct MOL2850 is a Class II device made by DiaSorin Molecular LLC, cleared under FDA 510(k) K143651 on 18 Mar 2015 and listed in FDA GUDID since 22 Sep 2016 (UDI-DI 20816101025569), active as of 23 Oct 2026. One FDA recall is linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

510(k) K143651

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number20816101025569 UDI-DI Date22 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK143651 Date18 Mar 2015DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K143651 decided 18 Mar 2015 Active
  • FDA GUDID UDI-DI 20816101025569 listed 22 Sep 2016 Listed

Recalls

1 recall · FDA

    • Terminated Z-1274-2016 FDA Class I initiated 10 Feb 2016

    Focus Diagnostics is recalling the Direct Amplification Discs (DAD) supplied with the Simplexa HSV 1 & 2 Direct (MOL2150), Simplexa Flu A/B & RSV Direct (MOL2650) and Simplexa Group A Strep Direct kits (MOL2850) because it may result in a false negative result, a false positive result or Error code (s) 500 or 505, and it may result in higher invalid rates.

Timeline

3 dated events

  1. Cleared FDA 510(k) K143651
  2. Recall initiated FDA recalls Z-1274-2016
  3. Listed FDA GUDID 20816101025569

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Simplexa™ Group A Strep Direct
Generic name
Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
Model / Ref / Catalog
MOL2850
Primary DI / UDI-DI
20816101025569
510(k) Number
FDA product code
PGX
GMDN term
Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
Device class
Class II
Regulation number
866.2680
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code PGX (Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System).

Other devices from DiaSorin Molecular LLC

See all devices from DiaSorin Molecular LLC →

Properties

  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)